CARDIOGENI PLC
Company number 10541091 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£10,981,212
Balance sheet as at 2024-03-31
What it does
Celixir is a clinical development stage bio-pharmaceutical group formed as Cell Therapy Ltd in 2009 based on the pioneering work of co-founder, Professor Sir Martin Evans, winner of the 2007 Nobel Prize for Medicine.Celixir Limited is the parent company of the group; the activities of the group span research, development, commercialisation and manufacture of cellular medicines.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Public Limited Company
- Incorporated
- 2016-12-28
- Employees
- 4 (2024 accounts)
- Registered office
- Celixir House Stratford-Upon-Avon Business & Technology Park, Innovation Way, Stratford-Upon-Avon, England, CV37 7GZ
- Postcode
- CV37 7GZ
- Capital
- 974 GBP
- Accounts category
- Group
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-09-30
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-05-07
- Next due by
- 2027-05-21
Nature of business (SIC)
- 70100 Activities of head offices
- 70229 Management consultancy activities other than financial management
Officers 5 current · 1 resigned
Group structure 4 subsidiaries
From persons-with-significant-control filings on the public register.
Contact details
- Website
- celixir.co.uk
Previous company names
| Name | Date changed |
|---|---|
| CARDIOGENI LIMITED | 2025-01-06 |
| CELIXIR LIMITED | 2025-01-06 |
| CELIXIR PLC | 2021-02-17 |
Among its peers
Top 5%
by shareholders' funds, of 207 similar companies in CV
Among the biggest employers among its local peers (4 staff).
Trading since 2016.
No.7 of the largest activities of head offices companies in Coventry →
Competitors Coventry
This company ranks 7 among activities of head offices in Coventry.
The class of 2016
44%
of the 2,103 companies in this sector incorporated in 2016 are still active today; 52% have since been dissolved.
A fact about the year, not a forecast for this company.